Mouth health and quality of life in children with hemophilia
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at the mouth health and quality of life of children with hemophilia. It aims to understand how hemophilia affects oral health so that better dental care can be provided.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have hemophilia (type A, B, or C), any severity (mild, moderate, or severe).
- Your child should not have any other major medical conditions (aside from hemophilia).
- Your child should not have a psychiatric disorder.
- Your child must not be taking certain medications that can cause gum problems, like cyclosporine or phenytoin.
- As a parent, you must agree to allow your child to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an educational program to help people with hemophilia manage chronic joint pain better. Participants will learn pain management skills that may improve daily comfort and quality of life.
This study looks at how prophylactic treatment for hemophilia affects your daily life, sleep, and feelings about your health. It compares different types of clotting factor concentrates to see if one is easier to manage than the other.
This study collects information from people with hemophilia about how treatments and daily life affect them. It uses your answers to improve patient-focused care and understand what challenges matter most.
This study compares how well children with hemophilia use their arms and hands compared to healthy children. If your child has hemophilia A or B, is on regular treatment, and has no inhibitors or recent bleeds in the arm, they may be able to join.
This study uses ultrasound to check if joints that are currently healthy stay healthy in people with hemophilia A who are taking emicizumab (Hemlibra) as their regular treatment. It aims to see if this treatment helps prevent joint damage over time.
This study follows up with young adults who have severe hemophilia to learn about their health and life as they grow into adulthood. It aims to understand the challenges they face and what helps them thrive.
Hear when a new Hemophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.